India In-vitro Diagnostic Reagents Market to Grow with a CAGR of 6.55% through 2030
The integration of advanced technologies and increasing incidence of
chronic diseases are expected to drive the India In-vitro Diagnostic Reagents
Market growth in the forecast period, 2026-2030
According to TechSci Research report, “India
In-vitro Diagnostic Reagents Market – By Region, Competition, Forecast and
Opportunities, 2030F”, the India In-vitro Diagnostic Reagents Market stood
at USD 1.68 billion in 2024 and is anticipated to grow with a CAGR of 6.55% in
the forecast period through 2030.
Integration of cutting-edge technologies such as
molecular diagnostics, next-generation sequencing, and advanced immunoassays
has significantly improved the accuracy, speed, and reliability of diagnostic
tests, making them attractive for investment and expanding market
opportunities. Automation and digitalization in laboratory systems have
streamlined workflows, reduced errors, and increased diagnostic capacity,
meeting the rising demand for precise diagnostics in India.
Demographic shifts, including an increasing burden of
chronic diseases like diabetes, cardiovascular conditions, and cancer,
necessitate frequent, reliable diagnostic testing, thereby driving demand for
IVD reagents. The aging population, susceptible to chronic and age-related
illnesses, requires comprehensive diagnostic solutions for timely medical
interventions. Expansion of healthcare infrastructure through investments in
hospitals, diagnostic centers, and laboratories enhances diagnostic service
accessibility across urban and rural areas. Government initiatives such as
Ayushman Bharat are expanding healthcare coverage, making diagnostic tests more
accessible and contributing to market growth for IVD reagents. Rising health
consciousness prompts proactive health management, increasing demand for
regular diagnostic testing and IVD reagents.
Health awareness campaigns by governmental and
non-governmental organizations emphasize the importance of regular health
screenings, fostering a culture of preventive healthcare and stimulating market
expansion. Economic growth in India has boosted disposable incomes, enabling
more individuals to afford advanced healthcare services, including diagnostic
tests. Increased healthcare spending by public and private sectors supports
infrastructure, services, and technology improvements, crucial for sustained
growth in the IVD reagents market. Strategic collaborations among diagnostic
firms, research institutions, and healthcare providers drive innovation, expand
market reach, and enhance the diagnostic ecosystem.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on " India In-vitro Diagnostic Reagents Market”
The India In-vitro Diagnostic Reagents Market is
segmented into test type, product, usability, application, end user, regional
distribution, and company.
Based on its application, the infectious diseases
segment has emerged as the predominant market leader, India faces significant
challenges due to endemic infectious diseases like tuberculosis (TB), malaria,
dengue, hepatitis, and more recently, COVID-19. These diseases persist and
spread in the country's large population density and diverse environmental conditions,
underscoring the need for robust diagnostic capabilities. Periodic outbreaks of
infectious diseases, such as seasonal flu and viral fevers, necessitate rapid
and accurate diagnostic testing to effectively contain their spread. Diagnostic
tests that detect specific pathogens during outbreaks play a crucial role in
mounting timely public health responses.
The infectious disease segment requires a diverse
array of diagnostic tests, including molecular assays, serological tests
(ELISA), rapid antigen tests, and nucleic acid amplification tests (NAATs).
These tests are essential for detecting viral, bacterial, and parasitic
infections, providing clinicians with critical information for patient
management. Government initiatives and public health programs often incorporate
screening for infectious diseases, particularly among high-risk populations.
These programs drive the demand for diagnostic tests capable of early
detection, enabling prompt treatment and effective disease control measures.
Technological advancements in diagnostic technologies
have revolutionized infectious disease diagnostics, improving sensitivity,
specificity, and testing speed. Molecular diagnostic techniques like PCR and
next-generation sequencing (NGS) enable rapid and accurate pathogen detection,
facilitating timely clinical decision-making. The development of rapid
diagnostic tests and point-of-care testing (POCT) devices for infectious
diseases has streamlined diagnostic workflows. These tests deliver quick
results at or near the patient’s location, enabling immediate medical
interventions and reducing the risk of disease transmission.
Major companies operating in India In-vitro Diagnostic
Reagents Market are:
- Abbott Laboratories Inc.
- Becton, Dickinson and Company
- F. Hoffmann-La Roche Ltd
- Transasia Bio-Medicals Ltd
- Thermo Fisher Scientific Inc
Download Free Sample Report
Customers can also request for 10% free customization
on this report
“India In-vitro Diagnostic Reagents market
demonstrates robust growth prospects driven by expanding healthcare
infrastructure, technological advancements enhancing diagnostic precision, and
proactive government initiatives promoting healthcare accessibility. With
increasing disease prevalence and a growing emphasis on preventive healthcare,
the market is poised for continued expansion, supported by ongoing innovations
and strategic investments in diagnostic capabilities across the country”, said
Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“India In-vitro Diagnostic Reagents Market, By Test Type (Clinical Chemistry, Molecular Diagnostics, Hematology, Immuno Diagnostics, Other), By Product (Instrument, Reagent, Other), By Usability (Disposable, Reusable), By Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, Other), By End User (Diagnostic Laboratories, Hospitals and Clinics, Other), By Region, Competition, Forecast and Opportunities, 2020-2030F”, has evaluated
the future growth potential of India In-vitro Diagnostic Reagents Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in India In-vitro Diagnostic Reagents Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com